10X Genomics (NASDAQ: TXG) — Company Overview, News & Financial Data
10X Genomics develops advanced genetic analysis systems, enabling significant enhancements in genetic research and biological discovery.
10X Genomics
10X Genomics is a life sciences technology company that develops microfluidic systems, instruments, consumables, and software for single-cell and spatial biology analysis. The company's platforms enable researchers to analyze biological systems at single-cell resolution and map gene expression within intact tissue samples. Its core product lines include Chromium for single-cell multiomics, Visium and Atera for spatial transcriptomics, and Xenium for targeted in situ tissue profiling. These integrated hardware, reagent, and software solutions are used by academic institutions, research centers, and biotechnology and pharmaceutical companies globally to support applications in oncology, immunology, neuroscience, and drug development.
Snapshot
Operations
Products and/or services of 10X Genomics
- Chromium Single Cell Platform: High-throughput single-cell analysis instruments, microfluidic chips, barcoded gel beads, and reagents enabling researchers to profile single-cell gene expression, cell surface proteins, and chromatin accessibility across thousands of individual cells.
- Visium Spatial Platform: Tissue profiling slides, reagents, and molecular assays designed to map whole transcriptome gene expression directly within intact tissue sections, enabling spatial analysis while preserving histological architecture across diverse biological samples.
- Xenium In Situ Platform: High-resolution molecular imaging instruments, custom and pre-designed gene panels, and automated onboard data analysis software for targeted subcellular visualization of RNA and protein targets within preserved tissue specimens.
- Atera In Situ Platform: High-capacity spatial transcriptomics instruments and whole-transcriptome tissue profiling panels engineered for subcellular resolution analysis across large sample cohorts and high-throughput biological studies in clinical and academic laboratories.
- Consumables and Assays: Single-use microfluidic chips, specialized barcoding reagents, library preparation kits, tissue slides, and assay reagents consumed continuously by laboratories running established analytical instruments for genomic and spatial workflows.
- Catalyst Research Services: Direct analytical and laboratory support services providing spatial whole-transcriptome processing, experimental setup, and custom assay design for academic institutions and biopharmaceutical organizations conducting large-scale biological research.
10X Genomics executive team
- Dr. Serge Saxonov Ph.D.Co-Founder, CEO & Director
- Dr. Benjamin J. Hindson Ph.D.Co-Founder, President, Chief Scientific Officer & Director
- Mr. Adam S. TaichCFO, Treasurer, Principal Financial Officer & Principal Accounting Officer
- Mr. Jim GoodrichChief of Global Operations
- Mr. Michael Schnall-Levin Ph.D.Founding Scientist & CTO
- Ms. Cassie CorneauManager of Investor Relations & Strategic Finance
- Dr. Randy WuGeneral Counsel and Secretary
- Ms. Mennah MoustafaChief Commercial Officer
- Mr. Jens DurruthyAssociate Director of Product Management